2A Biosciences

Breakthrough nerve regeneration through promotion of nerve growth factor and neuroplasticity.\r\nExtremely potent at small concentrations of drugs.\r\nHuge potential across therapeutic areas and diseases.

4 IND enabling development programs experience and 10 clinical trials run. Ex-Alcon and big pharma.\r\nLaunched 2A Biosciences' ophthalmology program.\r\n

Raised $5.25M from leading psychedelic investors and family offices.